Active Implants said yesterday that it won breakthrough device designation from the FDA for its NUsurface meniscus implant, the first of its kind to be marketed in Europe and, if cleared by the FDA, the first artificial meniscus in the U.S. Memphis-based Active Implants’ NUsurface implant is an investigational treatment for patients suffering from persistent […]
From 3M’s expanded 510(k) clearance for its Tegaderm dressing to Medtronic and Acacia burying the hatchet, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. InspireMD inks Taiwanese distro deal for CGuard InspireMD announced in a June 8 press release that it has signed a distribution deal with […]
Active Implants said today that it banked the 1st $10 million tranche of its $40 million Series D round. New backer LS Health Science Partners led the round with the 1st tranche and is due to put up another $20 million, with the remaining $10 million slated to come from existing investors, the Memphis-based company said. Active […]
Teleflex (NYSE:TFX) said this month that CEO Benson Smith will retire from the corner office by the end of this calendar year. Smith will continue to serve as the company’s chairman of the board. Liam Kelly, president & chief operating officer, was tapped to succeed Smith as CEO for the Wayne, Pa.-based company. “I want to […]
Active Implants said today it launched a new site at in its Venus trial looking to investigate its NUsurface investigational meniscus implant for treating persistent knee pain caused by deteriorating or injured meniscal cartilage. The NUsurface is made from medical grade plastic and is designed to not require fixation to bone or soft tissue by mimicking the function of […]
Active Implants said today it launched a 2nd clinical trial to evaluate its NUsurface meniscus implant designed to be meniscus replacement for patients looking to avoid or delay total knee replacement procedures. Active Implant’s SUN trial is slated to enroll 120 patients with persistent knee pain caused by injury or deterioration at up to 20 sites, the […]
Orthopedics devices maker Active Implants touted the close of the 1st $8.7 million tranche in a $26 million financing round in support of its NUsurface meniscus implant for repairing damage in the knee.
The Tennessee-based company plans to use the funds to advance clinical trials in pursuit of U.S. regulatory approval, the company said.